06/01
Headlines

Richard Atkins

Richard Atkins is a senior contributor at Tech Insider covering online media, online travel, and video games. Richard has been with Tech Insider covering companies in these industries since 2011 and has authored numerous industry reports, including "Internet Video: Field of Dreams or Nightmare on Elm Street," "The Next Leg of Online Travel," and "Pwned: How Casual Games Changed The Gaming Landscape." Atkins was recognized as the No. 2 stock picker and earnings estimator in the 2011 Financial Times / StarMine Internet & Catalog Retail category and was ranked in the 2010 Wall Street Journal "Best On The Street" for the Leisure Goods & Services category.

Solar Stocks: ReneSola (NYSE:SOL), Hanwha Solarone (NASDAQ:HSOL), SolarCity Corp (NASDAQ:SCTY), Yingli Green Energy (NYSE:YGE)

Richard Atkins02 mins

ReneSola Ltd. (ADR)(NYSE:SOL) on Mar. 5 announced it has delivered approximately 45,900 of its high-efficiency modules to the Photovoltaic Plant of Ferrara Aranova project, a 11.7MW ground-mounted solar project in Italy developed by Tozzi Sud S.p.A., an Italian designer, manufacturer, and installer of power plants. ReneSola Ltd. (ADR) (NYSE:SOL) stock performance was -5.23% in last…

Read More

Biotech Unusual Volume: Agios Pharmaceuticals (NASDAQ:AGIO), OHR (NASDAQ:OHRP), La Jolla (NASDAQ:LJPC), Aastrom Biosciences (NASDAQ:ASTM)

Richard Atkins02 mins

Agios Pharmaceuticals (NASDAQ:AGIO) was downgraded by Zacks from a “neutral” rating to an “underperform” rating in a research report issued to clients and investors on Monday, Analyst Ratings News reports. Agios Pharmaceuticals Inc (NASDAQ:AGIO) stock performance was 2.84% in last session and finished the day at $46.74. Traded volume was 983,271 million shares in the…

Read More

Biotech Top Gainers: Northwest Biotherapeutics (NASDAQ:NWBO), Alexion Pharmaceuticals (NASDAQ:ALXN), Merrimack Pharmaceuticals (NASDAQ:MACK), Enzon Pharmaceuticals (NASDAQ:ENZN)

Richard Atkins02 mins

German health regulators have granted Northwest Biotherapeutics Inc (NASDAQ:NWBO) special permission to sell its experimental brain cancer drug, DCVax-L, in the country, even though the small US biotechnology company has not yet completed its late-stage trial of the immunotherapy. Northwest Biotherapeutics, Inc (NASDAQ:NWBO) stock performance was 29.55% in last session and finished the day at…

Read More

Financial Movers: National Bank of Greece (NYSE:NBG), Freddie Mac (OTCBB:FMCC), Camtek (NASDAQ:CAMT), Rosetta Genomic (NASDAQ:ROSG)

Richard Atkins02 mins

Shares of National Bank of Greece (NYSE:NBG) are up nearly 10% Monday following Deutsche Bank’s new coverage of the stock at a Buy rating and EUR4.50 price target (approx $6.25 based on Monday’s exchange rate). The rating results from Deutsche Bank’s forecast for a strong recovery in fundamentals for the Greek banking sector. In addition,…

Read More

Overbought NYSE Stocks: Six Flags Entertainment (NYSE:SIX), Greenbrier Companies (NYSE:GBX), Barnes & Noble (NYSE:BKS), BEAM Inc (NYSE:BEAM)

Richard Atkins02 mins

New Orleans’ latest call for someone to take on the redevelopment of the blighted former Six Flags Entertainment Corp (NYSE:SIX) theme park received just one response. Six Flags Entertainment Corp (NYSE:SIX) stock performance was 0.10% in last session and finished the day at $42.06. Traded volume was 644,131.00million shares in the last session and the…

Read More